Revolutionizing disease prevention, detection, and treatment through Machine Learning

Community Jameel and MIT have announced their fourth major collaboration that aims to help revolutionize the future of healthcare – the Abdul Latif Jameel Clinic for Machine Learning in Health, or ‘J-Clinic’.

J-Clinic, a key part of the MIT Quest for Intelligence, will focus on developing machine learning technologies to revolutionize the prevention, detection, and treatment of disease.  It will concentrate on creating and commercializing high-precision, affordable, and scalable machine learning technologies in areas of healthcare ranging from diagnostics to pharmaceuticals, with three main areas of focus:

  • Preventative medicine methods and technologies with the potential to change the course of the non-infectious disease by stopping it in its tracks.
  • Cost-effective diagnostic tests that may be able to both detect and alleviate health problems.
  • Drug discovery and development to enable faster and cheaper discovery, development, and manufacture of new pharmaceuticals, particularly those targeted for individually customized therapies.

J-Clinic’s holistic approach will utilize MIT’s strong expertise in cellular and medical biology, computer science, engineering, and the social sciences, amongst other areas.

J-Clinic will capitalize on MIT’s strong relationship with industry and health care providers to test, integrate, and deploy new technologies.  It will also seek to advance patentable research that could be commercialized and spun-out through licensing to startups and pharmaceutical companies.

“Channeling MIT’s machine learning expertise into healthcare will transform medical outcomes for people around the world,” said Hassan Jameel, President of Community Jameel Saudi Arabia.

“Healthcare has been an important sphere of activity for Community Jameel since our earliest days. J-Clinic continues our journey of supporting cutting-edge research and driving innovation in healthcare.” 

Anantha P. Chandrakasan, dean of the MIT School of Engineering and Vannevar Bush Professor of Electrical Engineering and Computer Science, who will serve as J-Clinic’s chair, commented: “J-Clinic will positively impact the world by accelerating the creation of machine learning technologies and algorithms that will make preventing, detecting, and treating disease more precise, affordable, and personalized.”  

Earlier collaborations between MIT and Community Jameel include the Abdul Latif Jameel Poverty Action Lab (J-PAL), established in 2003, which seeks answers to poverty in a changing world; the Abdul Latif Jameel Water and Food Systems Lab (J-WAFS), created in 2014, which addresses food and water scarcity and safety issues as the result of population rises and climate change; and the Abdul Latif Jameel World Education Lab (J-WEL), launched in 2017, which pursues innovative, scalable, and sustainable educational innovation.

Community Jameel and MIT have also collaborated in the Abdul Latif Jameel-Toyota Endowed Scholarship since 1994 and the MIT Enterprise Forum Arab Startup Competition and a Saudi Start-up Competition.

To keep up to date with the work of J-Clinic, sign-up for the newsletter here.

Related Articles

© 2016-2018 Abdul Latif Jameel IPR Company Limited. Permission to use this site is granted strictly subject to the Terms of Use. The Abdul Latif Jameel name, and the Abdul Latif Jameel logotype and pentagon-shaped graphic are trademarks, or registered trademarks of Abdul Latif Jameel IPR Company Limited.